Die Grafik zeigt die prognostizierten Quartalsgewinne (Bereinigter Gewinn pro Aktie, EPS) und die tatsächlich erzielten Gewinne (grün: Analystenschätzungen übertroffen, rot: Analystenschätzungen verfehlt) für den ausgewählten Zeitraum.
Umsatz (USD)
Schätzung
Umsatz
Die Grafik zeigt die prognostizierten Quartalsumsätze und die tatsächlich erzielten Umsätze (grün: Analystenschätzungen übertroffen, rot: Analystenschätzungen verfehlt) für den ausgewählten Zeitraum.
Güte der Analystenschätzungen – EPS (aktueller Zeitraum)
Quartal / Datum
EPS (USD)
Schätzung (USD)
Abweichung
Quartal / Datum
Umsatz (Mio USD)
Schätzung (Mio USD)
Abweichung
Revisionen der Gewinnschätzungen
EPS-Schätzungen für die Geschäftsjahre
2026, 2027, 2028.
WESTCHESTER, Ill., May 20, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions, announced today that its board of directors declared a quarterly dividend of $0.82 per share on the Company's common stock.
Ingredion Incorporated (INGR) remains a Buy, supported by strong financials and robust cash generation despite recent operational setbacks and macro pressures. Q1 results were weak due to Argo facility issues, leading to reduced 2026 guidance and highlighting operational and cost risks. Potential acquisition of Tate & Lyle could transform INGR, expanding geographic reach significantly and helping to diversify into higher-growth segments.
Britain's Tate & Lyle on Thursday said it was in discussions with U.S. rival Ingredion over a possible takeover of the food ingredients maker, valuing it at 2.74 billion pounds ($3.70 billion), after receiving multiple approaches.
An Innovation Powerhouse: The initiative unites world-class experts in FoodTech, pet care, and ingredients to accelerate the transition toward a more sustainable pet food supply chain. Seeking New and Scaling Ventures: The program is in pursuit of bold companies with groundbreaking solutions in alternative proteins, fats, oils and novel ingredients.
Ingredion NYSE: INGR reported a weaker-than-expected first quarter of 2026, as operational problems at its Argo facility weighed heavily on results in its Food & Industrial Ingredients U.S. Canada segment, while its Texture & Healthful Solutions business continued to post volume growth.
Ingredion (INGR) came out with quarterly earnings of $2.34 per share, missing the Zacks Consensus Estimate of $2.44 per share. This compares to earnings of $2.97 per share a year ago.
Portfolios
0
Zum Anlegen oder Bearbeiten von Portfolios müssen Sie sich anmelden oder einen Account erstellen.
Aktuelle Aktie in ein Portfolio speichern oder neues Portfolio anlegen: